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Background: The DEP domain is a globular domain containing approximately 90 amino acids, which was first
discovered in 3 proteins: Drosophila disheveled, Caenorhabditis elegans EGL-10, and mammalian Pleckstrin; hence
the term, DEP. DEPDC1B is categorized as a potential Rho GTPase-activating protein. The function of the DEP
domain in signal transduction pathways is not fully understood. The DEPDC1B protein exhibits the characteristic
features of a signaling protein, and contains 2 conserved domains (DEP and RhoGAP) that are involved in Rho
GTPase signaling. Small GTPases, such as Rac, CDC42, and Rho, regulate a multitude of cell events, including cell
motility, growth, differentiation, cytoskeletal reorganization and cell cycle progression.
Results: In this study, we found that it was a guanine nucleotide exchange factor and induced both cell migration
in a cultured embryonic fibroblast cell line and cell invasion in cancer cell lines; moreover, it was observed to
promote anchorage-independent growth in oral cancer cells. We also demonstrated that DEPDC1B plays a role
in regulating Rac1 translocated onto cell membranes, suggesting that DEPDC1B exerts a biological function by
regulating Rac1. We examined oral cancer tissue; 6 out of 7 oral cancer tissue test samples overexpressed DEPDC1B
proteins, compared with normal adjacent tissue.
Conclusions: DEPDC1B was a guanine nucleotide exchange factor and induced both cell migration in a cultured
embryonic fibroblast cell line and cell invasion in cancer cell lines; moreover, it was observed to promote
anchorage-independent growth in oral cancer cells. We also demonstrated that DEPDC1B exerts a biological
function by regulating Rac1. We found that oral cancer samples overexpressed DEPDC1B proteins, compared
with normal adjacent tissue. Suggest that DEPDC1B plays a role in the development of oral cancer. We revealed that
proliferation was linked to a novel DEPDC1B-Rac1-ERK1/2 signaling axis in oral cancer cell lines.
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The DEP domain is a globular domain containing ap-
proximately 90 amino acids, which was first discovered in
3 proteins: Drosophila disheveled, Caenorhabditis elegans
EGL-10, and mammalian Pleckstrin; hence the term, DEP
[1–3]. The DEP domain was observed to play a function
in mediating membrane localization and regulating a
broad range of cellular functions [4], from the determin-
ation of cell polarity to highly specialized signals in pho-
toreceptors of the retina. The DEP domain contains a
cluster of basic residues that enable it to interact with
negatively charged phospholipids located in membranes;
this may be required for Wnt signaling [5]. Moreover,
DEP domain proteins enable direct interaction with G
protein-coupled receptors and mediated GPCR signaling
pathways [6,7].
The function of the DEP domain in signal transduc-
tion pathways is not fully understood. The DEPDC1B
protein exhibits the characteristic features of a signal-
ing protein, and contains 2 conserved domains (DEP
and RhoGAP) that are involved in Rho GTPase sig-
naling. Small GTPases, such as Rac, CDC42, and Rho,
regulate a multitude of cell events, including cell motility,
growth, differentiation, cytoskeletal reorganization and
cell cycle progression [8]. Rac and Cdc42 activation
have been linked to the formation of lamellipodia and
filopodia, respectively, whereas Rho protein activation
has been associated with the formation of actin stress
fibers [9,10]. Among these GTPases, Rac1 activity has
been implicated in tumorigenesis in various tissues
[11,12]. Rac1 activation increases cell proliferation,
and alters cell migration and mitogen-activated pro-
tein kinase (MAPK) signaling. MAPK signaling, in-
cluding ERK, p38 and JNK, is involved in a variety of
cellular functions, such as growth, proliferation, differ-
entiation, and apoptosis [13]. Of the signaling path-
ways, ERK has been studied the most in-depth. ERK
activation induces numerous biological responses that
involve cell proliferation, angiogenesis, and differenti-
ation [14].
We found that DEPDC1B was highly expressed in oral
cancer tissue, compared with normal adjacent tissue.
The overexpression of DEPDC1B in cells promotes cell
migration and induces cell invasion in cancer cell lines.
The effects of DEPDC1B on both migration and invasion
are mediated by Rac1. DEPDC1B affects the loading and
augmentation of ERK1/2 activity by Rac1 GTP, which
subsequently causes colony formation in oral cancer
cells. We revealed a novel DEPDC1B-Rac1-ERK1/2 sig-
naling axis in the development of oral cancer cell lines.
The identification of molecular networks using DEPDC1
in this study could be useful for the future discovery of
novel therapeutic targets and diagnostic markers to treat
cancers.Methods
Northern blot analysis
A human tissue blot (Clontech) was hybridized with a
probe corresponding to DEPDC1B full-length cDNA
and labeled using an NEBlot random labeling kit (New
England BioLabs) in the presence of [α-32P] dCTP. The
blot was washed with SSC/SDS solution (sodium chlor-
ide, sodium citrate/SDS) before autoradiography.
Immunoprecipitation and western blot analysis
Cell lysates were prepared in IP buffer (40 mM Tris–HCl
[pH 7.5], 1% NP40, 150 mM NaCl, 5 mM EGTA, 1 mM
DTT, 1 mM PMSF, 20 mM NaF, proteinase inhibitors,
and 1 mM sodium vanadate). Cell extracts (600 μg) were
incubated with 5 μg of primary antibody for 6 h at 4°C,
mixed with 20 μL of protein-A sepharose suspension, and
incubated for an additional hour. Immunoprecipitates
were collected by centrifugation, washed 3 times with IP
buffer plus 0.5% deoxycholate, and 5 times with IP buffer
alone, before being subjected to SDS-PAGE. Immunoblot
analysis was performed with specific antibodies against,
Rho, CDC42, and Rac1 (Cell Biolab, Inc). Cell-expressing
DEPDC1B or the empty vector were harvested in lysis
buffer (50 mM Tris–HCl, pH 8.0/250 mM NaCl/1% NP-
40, 2 mM EDTA) containing 1 mM PMSF, 10 ng/mL leu-
peptin, 50 mM NaF, and 1 mM sodium orthovanadate.
Total proteins were then separated on SDS-PAGE then
Immunoblot analysis was performed with specific anti-
bodies against MAPKs, P38, pp38, pJNK, ppJNK, pERK,
and ppERK (Cell Signaling Technology) and specific pro-
tein bands were visualized using an ECL chemilumines-
cent detection system (Amersham).
Wound-healing assay
Cells seeded on 10-cm plates were cultured to confluency.
They were then scratched with a 200-μL pipette tip and
incubated in DMEM supplemented with 10% FBS. Images
were taken at 17 h with a Zeiss Axiovert 200 microscope.
Membrane and cytosol fractionation
Cells were cultured with 1 μg/mL doxycycline for 48 h
and then treated with a lysis buffer (20 mM Tris–HCl,
pH 7.5, 100 mM NaCl, 5 mM EDTA, 2 mM PMSF, 1×
protease inhibitor) at 4°C for 30 min. The samples were
centrifuged at 500 × g at 4°C for 10 min, and the pellets
were dissolved in lysis buffer plus 0.1% (w/v) Triton X-
100 for the membrane fractions. The supernatants were
recentrifuged at 15 000 rpm at 4°C for 20 min, and the
supernatants were saved as cytosolic fractions.
Cell migration assay
A migration assay using a Boyden chamber was performed
by filling the bottom well of the chamber with DMEM
medium containing 10% FBS. Wells were covered with
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8-μm pores (Neuro Probes, Inc.), and 1500 cells/well in
serum-free DMEM were added to the top chamber. The
Boyden chamber was incubated for 24 h at 37°C to allow
the possible migration of cells through the membrane
into the bottom chamber. Membranes were stained
using Giemsa stain. The cells in the bottom chamber were
counted using a grid fitted into the eyepiece of a phase
contrast microscope.
Experimental research reported in the manuscript has
been performed with the approval of the Institutional
Review Board of Taichung Veterans General Hospital
(IRBTCVGH No: 950727/C06134).
Results
Tissue distribution of DEPDC1B mRNA
To ascertain the expression pattern of the DEPDC1B gene,
we studied the endogenous expression of DEPDC1B
mRNA in various human tissues. Northern blot analysis of
the tissues demonstrated that the mRNA for DEPDC1B
was 4.6 kb. DEPDC1B gene expression was only detected
in a few tissues, and was abundant in the placenta and
testis, and relatively scarce in the heart and small intestine
(Figure 1A). The open reading frame of DEPDC1B encodes
a putative polypeptide of 530 amino acids, with a calculated
molecular mass of 58.3 kDa. To ascertain the expression
and molecular weight of DEPDC1B, 293 T cells were trans-
fected with plasmids expressing a FLAG-tagged DEPDC1B
construct. The expressed proteins were determined using
western blot analysis, using an antibody specific for
FLAG. A band at a molecular weight of 59 kDa was de-
tected (Figure 1B). To evaluate the expression level of
DEPDC1B protein in oral cancer tissue, we performed an
immunoblotting assay using human oral cancer tissue. Among
the 7 oral cancer tissues that were evaluated, 6 overexpressed
DEPDC1B proteins in comparison with normal adjacent
tissue (Figure 1C). The data suggested that DEPDC1B
may play a role in the development of oral cancer.
Expression of DEPDC1B modulates Rac1 cellular localization
in rat embryonic fibroblasts
DEPDC1B encodes a protein that may function as a Rho
GTPase-activating protein (GAP), according to its intrinsic
primary protein sequences; therefore, it may play a role
in regulating Rho GTPase activity. Many studies have in-
dicated that Rho GTPases act as molecular switches by cyc-
ling between the inactive GDP-bound form located in the
cytoplasm and an active membrane-associated GTP-bound
form. The activities of Rho family proteins are regulated by
various proteins, such as guanine nucleotide exchange fac-
tors (GEFs), GAPs, and GDP-dissociation inhibitors [15].
We then characterized the biological effects of DEPDC1B
on cultured cell systems. We generated stable rat em-
bryonic fibroblast, Rat6, and hepatoma Hep3B cells thatexpressed DEPDC1B under tetracycline-responsive transacti-
vator control. In this system, the addition of the tetracycline
analog doxycycline induced the expression of DEPDC1B.
We then sought to determine whether DEPDC1B stimu-
lated the expression or activities of these GTPases in cul-
tured cells by using western blotting. Total Rac1 and Rho
levels remained the same in DEPDC1B-overexpressing
cells (Figure 1D). We therefore concluded that DEPDC1B
might not regulate the expression of these Rho GTPases.
Because DEPDC1B encodes a putative protein that could
function as a regulator or be physically associated with
Rho GTPases, we sought to determine whether DEPDC1B
was able to bind to these Rho GTPases. This interaction
was investigated using in vivo coprecipitation. 293 T cells
were transfected with plasmids that expressed a FLAG-
tagged DEPDC1B. Protein complexes were immunopre-
cipitated using antiFLAG antibodies. Coprecipitated Rho
GTPase proteins were detected by Rac1, CDC42, or RhoA
antibodies in immunoblotting analysis. As illustrated
in Figure 1E, Rac1 protein was detected in the FLAG-
DEPDC1B immunoprecipitated complexes, indicating that
DEPDC1B proteins may have physically interacted with
the Rac1 protein. Therefore, DEPDC1B might be a poten-
tial RhoGEF and contribute to the activation of Rac1.
To further address the question of whether DEPDC1B
influences Rho GTPase activity, a detergent-insoluble
membrane fraction was prepared from DEPDC1B-
overexpressing cells, and membrane-associated GTPases
were determined using western blotting. The level of
membrane-associated Rac1 increased in DEPDC1B-
overexpressing cells, whereas the cytosolic form of Rac1
decreased (Figure 1F). The membrane-associated and
cytosolic forms of RhoA remained unchanged in DEPDC1B-
expressing cells compared with parental cells. Therefore,
overexpression of DEPDC1B in cells increased the level
of membrane-associated Rac1, which was dissociated
from expression levels of Rac1 protein. We detected the
amount of GTP-bound Rac1 in Rat6 and Hep3B DEPDC1B-
expressing cells, and determined that DEPDC1B stimu-
lated GTP loading in Rac1 (Figure 1G). The expression of
DEPDC1B in both Rat6 or Hep3B cells increased the level
of membrane-associated Rac1 and GTP loading in Rac1.
Rac1 controls cell adhesion and motility
Our data suggested that DEPDC1B was able to bind to
and regulate Rac1 activities. To test the effect of DEPDC1B
on cell migration, confluent monolayers of cells that stably
expressed DEPDC1B were scrape-wounded with a sterile
plastic pipette, and the migration of cells into the wound
was monitored. The DEPDC1B-expressing cells closed the
wound area faster than the control cells (Figure 2A). To
determine whether DEPDC1B played a role in the induc-
tion of cell proliferation, contributing to faster wound heal-







Figure 1 (See legend on next page.)
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Figure 1 Expression patterns of DEPDC1B in normal tissues and tumor cells and effects of DEPDC1B on Rho GTPase expression and
the subcellular localization of Rac1. (A) Expression of DEPDC1B mRNA as presented by northern blot analysis of various human tissues, by
using DEPDC1B cDNA as a probe. A human multiple tissue northern blot containing poly (A)+ RNA was probed with full-length DEPDC1B DNA.
(B) FLAG epitope-tagged forms of DEPDC1B were transiently expressed in 293 T cells, and FLAG-DEPDC1B proteins were detected by using
antiFLAG antibodies with a molecular weight of approximately 58 kDa. (C) DEPDC1B protein was abundantly expressed in oral cancer
tissue (T) compared with cognate normal tissue (N). (D) Rho, and Rac1 were detected by western blotting of cell lysates from Rat6 cells
stably expressing DEPDC1B. (E) 3X FLAG epitope-tagged forms of DEPDC1B were transiently expressed in 293 T. Anti-FLAG antibodies
were used for immunoprecipitation. Anti-Rho, −CDC42, and -Rac1 antibodies were used for western blotting. (F) Membrane (Mem.) and cytosolic
(Cyto.) fractions from Rat6 or Hep3B/T2 control (C) and DEPDC1B-expressing cells were analyzed using immunoblotting for Rac1 and RhoGDIβ.
(G) GTP loading in Rac1 was determined and a PAK PBD binding assay was used to analyze in Rat6 or Hep3B/T2 cells that stably expressed DEPDC1B.
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ference between the growth rates of DEPDC1B-expressing
cells and control cells (Figure 2B). DEPDC1B-regulated cell
migration was not mediated through increased cell cycle
progression. We used migration assays to confirm the role
of DEPDC1B in cell migration. DEPDC1B-expressing cells
and parental cells were seeded on a porous filter in the
upper chamber of a transwell. The migration through
the filter pores of Rat6 cells expressing DEPDC1B was
increased compared with parental cells (Figure 2C). To
further confirm the role of DEPDC1B in cell invasion,
DEPDC1B-expressing hepatoma cells and parental cells
were seeded on a porous filter in the upper chamber of
a transwell, with matrigel present on top of the filter.
DEPDC1B-expressing hepatoma cells exhibited a sub-
stantially increased invasion rate compared with the par-
ental cells (Figure 2D). The data suggested that when
DEPDC1B was expressed in cells, cellular motility was
stimulated and invasion ability in tumor cells increased.
To test whether the effect of DEPDC1B on cell migra-
tion was Rac1-dependent, DEPDC1B cells were transfected
with plasmids harboring wild-type Rac1 (Rac), dominant-
negative Rac1 (RacN17), and constitutively active Rac1
(RacV12) (Figure 2E). Confluent monolayers of cells stably
expressing DEPDC1B, DEPDC1B-Rac1, or DEPDC1B −
Rac1N17, DEPDC1B − Rac1V12 were scrape-wounded
with a sterile plastic pipette, and the migration of cells into
the wound was monitored. As previously demonstrated,
DEPDC1B-expressing cells closed the wound area fas-
ter than the control cells (Figure 2F). The DEPDC1B-
Rac1N17 cells migrated more slowly than the DEPDC1B,
DEPDC1B-Rac1 and DEPDC1B-Rac1V12 cells (Figure 2F),
suggesting that Rac1 plays a key role in mediating cell
migration in DEPDC1B-expressing cells. These findings
indicated that DEPDC1B-induced cell migration in Rat6
cells was mediated through the increase of membrane-
associated Rac1 and stimulation of GTP loading in Rac1.
This suggests that DEPDC1B stimulated cell migration
that was mediated through Rac1.
Because the small GTPase Rac1 acted as a bridge for
DEPDC1B to induce cellular functions, we tested the role
of DEPDC1B to see whether it potentiated tumor forma-
tion in an oral cancer cell line, KB. We then measured theoverexpression of DEPDC1B in KB cells. These cells were
tested for their ability to grow in soft agar.
DEPDC1B potentiates colony formation in KB cells
The overexpressed DEPDC1B protein in KB cells po-
tentiated to colony formation by approximately 1.7
fold, compared with vector-transfected parental cells
(Figure 3A). The data suggested that DEPDC1B proteins
stimulated anchorage-independent growth in an oral can-
cer cell line. To confirm the expression of DEPDC1B in
such oral cells, we employed a PAK PBD pull-down assay
to test whether the DEPDC1B expressed in oral cancer
cells induced GTP loading in Rac1 proteins. Figure 3B il-
lustrates that DEPDC1B proteins increased GTP loading
in Rac1 proteins in oral cancer cells when the cells were
growing in adherent or nonadherent conditions. These re-
sults indicated that DEPDC1B was a potential GEP in all
tested cells, including Rat6, Hep3B, and KB cells.
To determine whether DEPDC1B played a role in the
induction of cell proliferation in oral cancer cells, we ex-
amined the growth rate when cells were both with and
without the DEPDC1B expression, in growth conditions
of adhesion and non-adhesion (Figure 3C and D). We
found that DEPDC1B-expressed cells exhibited a higher
growth rate than the control mock-transfected cells in
anchorage-independent conditions, whereas there was no
substantial change to adherent conditions. The results in-
dicated that DEPDC1B was able to promote cancer cell
proliferation in nonadherent conditions. Moreover, the
overexpression of DEPDC1B in cells can trigger Rac1 acti-
vation. We then tested whether the ability of DEPDC1B
to promote growth was mediated through Rac1. The
anchorage-independent growth ability in soft agar of the
mutant Rac1 (Rac1 N17) coexpressed with DEPDC1B in
these cells and oral cancer cells was examined and com-
pared with DEPDC1B cells. We confirmed that the cell
proliferation ability induced by DEPDC1B was abolished
with the coexpressed Rac1 N17 proteins in oral cancer
cells (Figure 3E). The results indicated that the biological
function of DEPDC1B proteins to induce cell proliferation
was mediated through Rac1 proteins.
We used migration and invasion assays to confirm the






Figure 2 DEPDC1B effects on the induction of cell migration in Rat6 cells and tumor cell invasion was Rac1-dependent. (A)Wound-healing
assay. Rat6 cells and Rat6 cells ectopically expressing DEPDC1B were seeded onto plates. After reaching confluency, the cell layer was wounded with
a 200-μL pipette tip and incubated for 24 h. (B) Growth curves of Rat6 cells with and without expression of DEPDC1B. Stable Rat6 cell lines were
seeded at an original density of 5000 cells per 6 well dishes, and cell numbers were counted at the indicated time. (C) DEPDC1B enhanced cell
migration in Rat6 cells. Migration was measured by quantifying the number of cells that had migrated to the lower chamber of a Boyden chamber
after 16 h. (D) DEPDC1B enhanced cell invasion in Hep3B/T2 cells. Invasion was measured by quantifying the number of cells that had migrated to the
lower chamber of a Boyden chamber after 16 h. (E) Control Rat6 and Rat6 DEPDC1B-expressing cells stably transfected with Rac1, Rac1N17, or Rac1V12
were grown in 10% fetal bovine serum; Rac1 expression levels were determined. (F) Wound-healing assay. The cell lines were seeded on
plates, as previously described. After reaching confluency, the cell layer was wounded with a 200-μL pipette tip and incubated for 17 h.
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Figure 3 Soft agar colony formation by KB and KB-DEPDC1B cells and DEPDC1B-enhanced anchorage-independent growth was
Rac1-dependent. (A) The upper panel presents relative colony size and the lower panel presents the quantitation of the results. The
lower panel shows the ectopic DEPDC1B expression levels. (B) GTP loading in Rac1 was determined and the PAK PBD binding assay
was used to analyze in KB or DEPDC1B-expressed KB cells in adherent and nonadherent cultured conditions. (C) Stable KB cell lines were
seeded at an original density of 5000 cells per 6 well dishes, and the cell number was counted at the indicated time. (D) Stable KB
cell lines were seeded at an original amount of 10 000 cells in a 50-mL conical tube with methylcellulose; cell numbers were counted
at the indicated time. (E) Control KB and KB DEPDC1B-expressing cells stably transfected with Rac1 or Rac1N17were grown in soft agar.
(F) DEPDC1B enhanced cell migration (M) and invasion (I) in KB cells.
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seeded on a porous filter in the upper chamber of a
transwell. The migration and invasion through the fil-
ter pores of KB cells expressing DEPDC1B was in-
creased compared with parental cells (Figure 3F). The
data suggested that when DEPDC1B was expressed in
oral cancer cells, cellular motility and invasion ability
was stimulated.DEPDC1B induces cell growth through a DEPDC1B-Rac1-ERK1/2
signaling
To investigate whether DEPDC1B regulated additional
signal transduction pathways, we tested DEPDC1B pro-
teins on the activation of MAPK pathways (including p38
MAPK, JNK, and ERK). For all the MAPK pathways
tested, we observed that the expression of DEPDC1B pro-
teins in oral cancer cells induced p38 MAPK and ERK
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To determine which MAPK pathway mediated growth
induced by DEPDC1B, we employed kinase-specific in-
hibitors (SB203580, SP600125, U0126, and PD98059)A
C
D
Figure 4 (See legend on next page.)to determine whether the anchorage-independent growth
rates were influenced by the treatment of these inhibitors.
SP600125-treated DEPDC1B-expressed or parental cells
grew as many colonies as cells that were not treated usingB
(See figure on previous page.)
Figure 4 MAPK activity followed KB cells transfected with DEPDC1B expression plasmids. (A) Following the transfection of KB cells with
DEPDC1B expression plasmids in adherent and nonadherent culture conditions (AIG), ERK and p38 MAPK activities were induced, whereas JNK
activities were suppressed (AIG). 50 μg of total cellular proteins were analyzed using western blotting and probed with specific antibodies.
(B) DEPDC1B induced soft agar colony formation not mediated through JNK or p38. KB and KB-DEPDC1B cells were inoculated into soft agar
medium containing different concentrations of either SB203580 or SP600125 (10 μM). (C) DEPDC1B induced soft agar colony formation mediated
through ERK. KB, KB-DEPDC1B, and KB-DEPDC1B-Rac1 cells were inoculated into soft agar medium containing different concentrations of either
U0126 or PD98059 (0, 2, 5, 10 μM). The results are presented as mean ± S.E. *, P < 0.05, **, 0.001≤ P < 0.01, ***, P < 0.001. The lower panel indicates
the concentration of drug to block activity of ERK and at the concentration of 10 μM PD98059 has the most significant to block ERK activity to 50%.
(D) DEPDC1B-enhanced ERK activation was Rac1-dependent. Stable KB cell lines were seeded in a 50-mL conical tube with methylcellulose.
Cell lysates were harvested 72 h later. Subsequently, 50 μg of total cellular proteins were analyzed using western blotting and probed with
specific antibodies.
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activities were not involved in the promotion of growth
in DEPDC1B-expressed cells, whereas cells treated with
SB203580 grew more colonies than the cells that were not
treated using this inhibitor (Figure 4B). Because p38 MAPK
activities were induced by the expression of DEPDC1B in
cells, it was assumed that increasing p38 MAPK activity
correlates with the promotion of anchorage-independent
growth induced by DEPDC1B. However, treatment with
p38-MAPK-specific inhibitors increased colony formation
in DEPDC1B-expressed cells, suggesting that p38 MAPK
caused the opposite effect on growth-promoting proper-
ties. Neither p38 MAPK nor JNK activity mediated the
promotion of anchorage-independent growth induced
by DEPDC1B. Whereas all cells (parental, DEPDC1B-
expressed, and Rac-expressed) were treated using U0126
or PD98059, the anchorage-independent growth induced
by DEPDC1B was suppressed by both inhibitors in a dose-
dependent manner (Figure 4C). The results suggested that
ERK activity mediates growth promotion induced by the
expression of DEPDC1B and Rac in oral cancer cells. To
determine whether DEPDC1B activation of ERK was
mediated through Rac, we cotransfected DEPDC1B with
dominant-negative Rac (Rac N17), and found that ERK ac-
tivity induced by DEPDC1B were influenced by the expres-
sion of Rac N17 proteins. This data indicated that Rac acted
as an intermediate molecule downstream of DEPDC1B
for ERK activity (Figure 4D). We found that DEPDC1B
was a growth-promoting protein that activated Rac and then
triggered ERK activity to enhance anchorage-independent
growth in oral cancer cells.
Discussion
In this paper, we report the identification and characterization
of a novel gene, DEPDC1B (DEP domain-containing 1B),
which was found to be considerably expressed in placenta
and the testis, but less so in the heart and small intestine.
The northern blotting analysis results indicated that the
gene was not detectable in other kinds of human tissue.
DEP domain-containing proteins regulate numerous cel-
lular functions; DEP domain-containing proteins include
signaling proteins, including disheveled, EGL-10 andPleckstrin. DEPDC1B harbors a DEP domain. DEP do-
mains can be found in Rho family GEFs, as well as in cer-
tain GAPs; however, its biological role in cells has not
been investigated. To elucidate the biological role of
DEPDC1B, we cloned DEPDC1B cDNA. This cDNA was
then subcloned into mammalian expression vectors. We
found that DEPDC1B regulated Rac1 activities by increas-
ing GTP loading in Rac1 did not affect Rho A activities in
either normal or cancer cells. In an immunoprecipitation
experiment, we found that DEPDC1B was able to physic-
ally interact with Rac1, but not Rho A or CDC 42. We
demonstrated that DEPDC1B proteins function as GEFs
and specifically activate Rac1.
Rac1 GTPase participates in regulating the migration,
invasion, transformation, growth, and survival of tumor
cells [16]. Because DEPDC1B acts as an upstream regula-
tor for Rac1, testing the mobility of DEPDC1B-expressing
cells can be beneficial. DEPDC1B plays a regulatory role
by functioning as a GEF that activates Rac1 proteins and
triggers migration in normal cells and invasion in tumor
cells.
We described a finding that revealed DEPDC1B pro-
teins were overexpressed in oral cancer tissue, compared
with normal adjacent tissue, in 6 out of 7 patients. We
then demonstrated that DEPDC1B proteins promoted
anchorage-independent growth in the KB cultured oral
cancer cell line. Our model suggested that DEPDC1B
was a positive modulator of Rac1 in oral cancer cell lines
cultured in both adherent and nonadherent conditions.
By using genetic approaches, we provided evidence that
DEPDC1B regulates anchorage-independent growth me-
diated through Rac1 in oral cancer cells. Furthermore,
DEPDC1B potentiates anchorage-independent growth
signals for the activation of ERK1/2, which critically me-
diates the functions of DEPDC1B. Our data revealed that
DEPDC1B affected Rac1 GTP loading and augmented
ERK1/2 activity, causing subsequent colony formation in
oral cancer cells. We revealed that the proliferation was
linked to the DEPDC1B-Rac1-ERK1/2 signaling axis in
the oral cancer cell lines. DEPDC1B, acted as a potentially
oncogenic protein in oral cancer patients, contributing to
the sustained elevation of ERK1/2 activity throughout the
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activity regulates cancer cell proliferation and is a crucial
factor in cancer progression. Our results suggested a novel
route by which DEPDC1B regulates Rac1 activation
and modulates ERK1/2 activities, and offer an explanation
for the mechanism by which DEPDC1b contributes to
anchorage-independent growth in oral cancer cells.
Conclusion
DEPDC1B was a guanine nucleotide exchange factor
and induced both cell migration in a cultured embry-
onic fibroblast cell line and cell invasion in cancer cell
lines; moreover, it was observed to promote anchorage-
independent growth in oral cancer cells. We also demon-
strated that DEPDC1B exerts a biological function by
regulating Rac1. We found that oral cancer samples over-
expressed DEPDC1B proteins, compared with normal ad-
jacent tissue. Suggest that DEPDC1B plays a role in the
development of oral cancer. We revealed that proliferation
was linked to a novel DEPDC1B-Rac1-ERK1/2 signaling
axis in oral cancer cell lines.
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